SCHEMBL24266604

SCHEMBL24266604

c1ccc(-c2cccc(-c3nc4ccccc4nc3-c3ccc(-c4cccc5oc6ccccc6c45)cc3)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.44
LMNA P02545 4/20 0.41
KDM4E B2RXH2 3/20 0.41
GAA P10253 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 3/20 0.41
THRB P10828 1/20 0.41
PLA2G2A P14555 3/20 0.40
PLA2G4A P47712 3/20 0.40
NPSR1 Q6W5P4 1/20 0.38
PLA2G10 O15496 1/20 0.38
BACE1 P56817 1/20 0.37
DHODH Q02127 1/20 0.37
PIK3R1 P27986 1/20 0.37
PIK3CA P42336 1/20 0.37
CYP1A2 P05177 1/20 0.37
AKT1 P31749 1/20 0.37
AKT2 P31751 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23385367 1.00 L3MBTL1 (0.44) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23385484 0.97 L3MBTL1 (0.46) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23385485 0.95 L3MBTL1 (0.43) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23384925 0.95 L3MBTL1 (0.45) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23920326 0.93 L3MBTL1 (0.46) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23384928 0.92 PIK3R1 (0.46) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23385233 0.91 CYP1A2 (0.43) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23385022 0.89 L3MBTL1 (0.49) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23385203 0.89 BACE1 (0.37) L3MBTL1LMNAKDM4EGAATDP1
SCHEMBL23384866 0.88 L3MBTL1 (0.39) L3MBTL1LMNAKDM4EGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220384744-A1 A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2022-12-01 US disclosed
US-20220173322-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2022-06-02 US disclosed
US-20220059777-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2022-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220384744-A1 A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME TELO2, PIEZO1, LIMS1 L3MBTL1 32/4885LMNA 3884/4885KDM4E 3633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.